1. D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma. (18th April 2013) Authors: Gerrie, Alina S.; Mikhael, Joseph R.; Cheng, Lu; Jiang, Haiyan; Kukreti, Vishal; Panzarella, Tony; Reece, Donna; Stewart, Keith A.; Trieu, Young; Trudel, Suzanne; Chen, Christine I. Journal: British journal of haematology Issue: Volume 161:Number 6(2013:Jun.) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Once‐weekly (70 mg/m2) vs twice‐weekly (56 mg/m2) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION‐1 trials. (28th February 2020) Authors: Moreau, Philippe; Stewart, Keith A.; Dimopoulos, Meletios; Siegel, David; Facon, Thierry; Berenson, James; Raje, Noopur; Berdeja, Jesus G.; Orlowski, Robert Z.; Yang, Hui; Ma, Haijun; Klippel, Zandra; Zahlten‐Kumeli, Anita; Mezzi, Khalid; Iskander, Karim; Mateos, Maria‐Victoria Journal: Cancer medicine Issue: Volume 9:Number 9(2020) Page Start: 2989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thalidomide‐prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10. (10th October 2014) Authors: Kovacs, Michael J.; Davies, Gwynivere A.; Chapman, Judy‐Anne W.; Bahlis, Nizar; Voralia, Michael; Roy, Jean; Kouroukis, C. Tom; Chen, Christine; Belch, Andrew; Reece, Donna; Zhu, Liting; Meyer, Ralph M.; Shepherd, Lois; Stewart, Keith A. Journal: British journal of haematology Issue: Volume 168:Number 4(2015:Feb.) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗